New migraine-specific pharmacologic agents associated with less efficacy compared to triptans
1. For pain freedom and relief at 2 hours after dosage, new agents such as lasmiditan, rimegepant, and ubrogepant were ...
1. For pain freedom and relief at 2 hours after dosage, new agents such as lasmiditan, rimegepant, and ubrogepant were ...
1. Among patients with migraine without aura, 2-hour infusion of vasoactive intestinal polypeptide (VIP) initiated migraine attacks in 71% of ...
1. Intravenous eptinezumab-treated participants achieved significantly earlier freedom from headaches and from their most bothersome symptoms compared to placebo in ...
1. Rimegepant significantly reduced the mean number of migraine days per month between the last 4 weeks of treatment and ...
Migraines During Pregnancy and the Risk of Maternal Stroke 1. Women with migraines are at an increased risk of stroke ...
1. The authors of this prospective cohort study found that women who were denied a wanted abortion were found to ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.